Phages.fr
Nos dernières publications
Bacteriophage lambda’s high mutation rate is not solely due to MMR inefficiency
This study re-evaluated the mutation rate of phage lambda and its host, E. coli. It confirmed lambda's higher mutation rate but found that mismatch repair (MMR) inefficiency due to Dam methylation
Ecological Constraints Restrict the Benefits of Horizontally Acquired CRISPR-Cas Systems
This study explores the horizontal transfer of a type I-F CRISPR-Cas system from Pseudomonas aeruginosa to Pseudomonas fluorescens. While functional in the new host, its protective benefits depend on
Role of trehalose polyphleates in the interactions between therapeutic phages and Mycobacterium abs…
Mycobacterium abscessus is a multidrug-resistant bacterium causing severe infections in cystic fibrosis patients, where phage therapy shows promise as an alternative treatment. Testing phages on
Experimental evolution of a biocontrol agent: monitoring the adaptation of a bacteriophage (Tequint…
Evolution of a virulent Tequintavirus leads to an expansion in its host range and increases its virulence against resistant Salmonella enterica strains. Key mutations, particularly in the Long Tail
Rationalisation of the purification, formulation and packaging of anti-Staphylococcus aureus therap…
Preparing and preserving therapeutic phage suspensions is crucial for advancing phage therapy. By optimizing purification and formulation processes, this approach enhances phage shelf-life and
Mapping factors of phage specificity: the case of restriction-modification systems
Phages must bypass various bacterial defenses, including restriction-modification (RM) systems, which degrade foreign DNA with specific motifs. We propose a novel method using random sequences
Genomics-driven discovery of a family of RiPPs that protect Actinobacteria from phage infection
Bacteria produce numerous natural products to adapt to changing environments, but most of their functions are unknown. Genomic and synthetic biology studies reveal that some of these compounds,
Tackling Multidrug-Resistant E. coli: A Dual Strike Approach using a phage cocktail and a host-targ…
Description of a novel approach to combat multidrug-resistant E. coli ST131 by combining a cocktail of bacteriophages with the C910 compound, which inhibits host cell invasion. This strategy
The diversity of antiphage defense systems in prokaryotes
La course aux armements entre les phages et les bactéries a conduit au développement de divers mécanismes de défense pour les bactéries et de contre-mécanismes pour les phages. Alors que le nombre de
What bacterial defenses teach us about innate immunity?
In my presentation, I summarize recent findings on the conservation of innate immune pathways between prokaryotes and eukaryotes. I show that bacterial defense mechanisms can in turn catalyze the
Intervenants et intervenantes
Postdoctoral researcher - Synthetic Biology Unit, Institut Pasteur, Paris
PhD Student, "Bactériophage, bactérie, hôte" laboratory - Institut Pasteur, Paris, France
Postdoctoral researcher - Molecular Ecology and Evolution of Phages group, MMSB institute, Lyon
Postdoctoral researcher - Infectious Disease Research Institute in Montpellier
Titulaire d'une thèse d'exercice en Pharmacie (Lyon 1, 2021)
PhD Student - MuSE Team, Micalis institute, INRAE, Jouy-en-Josas.
Auteur d'une thèse en Microbiologie à Sorbonne université (en 2020). - Post-doctorant au Weizmann Institute of Science, Sorek Lab (en 2024)
Post-doctorante au laboratoire Molecular Diversity of Microbes, Institut Pasteur (en 2024)
Doctorant au laboratoire MDM, Institut Pasteur (en 2024)
Auteur d'une thèse de doctorat en soutenue à Université Paris Cité en 2024